29.12.2013 Views

Induced Moderate Hypothermia After Cardiac Arrest - American ...

Induced Moderate Hypothermia After Cardiac Arrest - American ...

Induced Moderate Hypothermia After Cardiac Arrest - American ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MCKEAN<br />

AACN Advanced Critical Care<br />

is beneficial only if the health care team knows<br />

how to care for this patient population. Nursing<br />

care and support is crucial. Patient management<br />

and the vital nursing care needed for this<br />

patient population are described below.<br />

Table 1: The Bedside Shivering<br />

Assessment Scale a<br />

Score<br />

Definition<br />

0 None: no shivering noted on palpation of<br />

the masseter, neck, or chest wall<br />

1 Mild: shivering localized to the neck<br />

and/or thorax only<br />

2 <strong>Moderate</strong>: shivering involves gross<br />

movement of the upper extremities (in<br />

addition to neck and thorax)<br />

3 Severe: shivering involves gross<br />

movements of the trunk and upper and<br />

lower extremities<br />

a Used with permission from Badjatia et al, “Metabolic Impact of<br />

Shivering During Therapeutic Temperature Modulation: The Bedside<br />

Shivering Assessment Scale,” Stroke, 2008, vol. 39, pp. 3242--3247. 21<br />

Prevention of Shivering<br />

Shivering is a natural body response to<br />

hypothermia. If this natural response is allowed<br />

to occur while inducing hypothermia, there<br />

may be difficulty in achieving the target temperature.<br />

Shivering increases metabolic rate and<br />

oxygen consumption. Most protocols use a<br />

combination of sedation and paralytic agents to<br />

prevent shivering especially during induction. 20<br />

Shivering is less likely to occur during the maintenance<br />

and warming phases. The paralytic<br />

may be stopped during the warming phase. 13,20<br />

Patients should be monitored for signs and<br />

symptoms of shivering, including a drop in<br />

mixed venous oxygen saturation, increase in<br />

respiratory rate, facial tensing, static tracing<br />

on the electrocardiogram, and palpation of<br />

muscle fasciculations on the face or chest. 13<br />

The Bedside Shivering Assessment Scale (Table 1)<br />

may be used by nurses to provide a universal<br />

assessment tool for shivering. 21 The nurse must<br />

ensure that analgesia and sedation are optimized<br />

and that the patient is intubated with<br />

the ventilator set to proper parameters to provide<br />

adequate ventilation prior to the start of<br />

the paralytic treatment. A train of 4 should be<br />

established prior to initiation of continuous<br />

paralytics and continued to be monitored for a<br />

goal of 1 out 4. 13,20 It may be difficult to obtain<br />

train of 4 assessments due to peripheral vasoconstriction<br />

during hypothermia. 13 The nurse<br />

might need to rely on clinical indicators such<br />

as overbreathing on the ventilator and spontaneous<br />

movement to know if the paralytic<br />

agent is optimized.<br />

Sedation and analgesic drugs, such as midazolam,<br />

fentanyl, and propofol, have a 30% to<br />

50% decrease in systemic clearance during<br />

hypothermia. For neuromuscular-blocking<br />

agents, such as vecuronium and atracurium,<br />

clearance is decreased 10% for every 1C<br />

below 37C. Their duration of action is also<br />

increased. 20 The least amount of drug should<br />

be used to provide the needed effect. During<br />

hypothermia, the amount of drug required<br />

may be less than what is typically used. 13 The<br />

health care team must be mindful that the<br />

patient may take longer to wake up after treatment.<br />

20 The paralytic and sedation medications<br />

should be stopped as soon as possible<br />

after the completion of induced hypothermia<br />

treatment.<br />

Vital Sign Monitoring<br />

A patient’s normal response to hypothermia is<br />

to increase the heart rate and vasoconstrict in<br />

an attempt to conserve heat. The use of sedation<br />

and paralytic agents prevents this normal<br />

response to hypothermia. Bradycardia and<br />

increased systemic vascular resistance will be<br />

seen in the absence of shivering and with a continued<br />

decrease in temperature. The bradycardia<br />

is usually not hemodynamically significant<br />

and usually refractory to atropine. It is not<br />

always necessary to terminate treatment for<br />

patients who are bradycardic. Blood pressure is<br />

usually maintained without the use of vasopressors<br />

secondary to the increased systemic vascular<br />

resistance. Vasopressors may be used to<br />

maintain systolic blood pressure greater than<br />

90 mm Hg or mean arterial pressure greater<br />

than 60 mm Hg. The patient may be pale, and<br />

peripheral pulses may be difficult to obtain<br />

because of the vasoconstriction. The greatest<br />

risk for hypotension is during the warming<br />

phase secondary to vasodilation. It is critical at<br />

the start of warming that vital signs are monitored<br />

closely. 2,5,20 Ideally, an arterial catheter will<br />

be inserted for continuous blood pressure measurement.<br />

However, if one is not available, then<br />

noninvasive measurements should be obtained<br />

at least every 30 minutes and more often during<br />

induction of warming. 6,20<br />

Continuous electrocardiogram monitoring<br />

is imperative. Dysrhythmias are rare in mild<br />

348

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!